August's top stories: launching startups, hospitals cutting back on VC investing, GLP-1 drug prescriptions, and more

Get 25% off an annual STAT+ subscription and read more of our award-winning journalism. ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

www.statnews.com Join the STAT+ community today to get access to last month's top stories and much more. Subscribe now for 25% off your first year. CONSTANZA HEVIA FOR STAT How Y Combinator's only health care partner decides which startups are worth a shot by Mohana Ravindranath READ MORE ALEX HOGAN/STAT Hospitals are dialing back on venture capital investing by Tara Bannow READ MORE ADOBE Where are patients getting their prescriptions for GLP-1 drugs like Wegovy and Ozempic? by Katie Palmer READ MORE MORE TOP STORIES Alarmed by popularity of Ozempic and Wegovy, insurers wage multi-front battle by Elaine Chen As the obesity drug market grows, digital health companies juggle patients and payers by Katie Palmer What's behind the recent surge in Apellis' stock price? Growing confidence in the safety of its eye treatment by Adam Feuerstein Unicorn down: Following layoffs, Biofourmis CEO quietly departs by Mario Aguilar For brain-computer interfaces, the commercial hurdles may be bigger than scientific ones by Lizzy Lawrence FDA approves Sage Therapeutics' rapid-acting medication for postpartum depression but not major depression by Brittany Trang With new acquisitions, Humana and CVS hope to turn members into patients by Tara Bannow   SUBSCRIBE Friday, September 8, 2023       1 Exchange Place, Boston, MA 02109 ©2023, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us